The North America digital diabetes management market size exceeded USD 4,150 million in 2020 and is estimated to observe a growth rate of 18.6% from 2021 to 2027 led by increasing access to digital diabetes products owing to favourable reimbursement, interoperability, marketing approval, and speedy FDA.

North America Digital Diabetes Management Market | Statistics Report 2021-2027

North America Digital Diabetes Management Market Size,  By End-use (Hospitals, Home Settings, Diagnostic Centers & Clinics), By Product Type (Devices {Smart Glucose Meters, CGM, Insulin Pumps & Patches, Insulin Pens}, By Device Type [Wearable, Handheld], Services {Diabetes Apps, Software}), By Patient Type (Type 1, Type 2), Research Report, Country Outlook (U.S., Canada), Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2021 - 2027

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology

1.1&nbsp;&nbsp;&nbsp; Market definitions

1.2&nbsp;&nbsp;&nbsp; Forecast assumptions

1.3&nbsp;&nbsp;&nbsp; Data sources

1.3.1&nbsp;&nbsp;&nbsp; Secondary

1.3.1.1&nbsp;&nbsp;&nbsp; Paid sources

1.3.1.2&nbsp;&nbsp;&nbsp; Unpaid sources

1.3.2&nbsp;&nbsp;&nbsp; Primary

Chapter 2&nbsp;&nbsp;&nbsp;Market Summary

2.1&nbsp;&nbsp;&nbsp; North America digital diabetes management industry summary, 2016 &ndash; 2027

2.1.1&nbsp;&nbsp;&nbsp; Country trends

2.1.2&nbsp;&nbsp;&nbsp; Product type trends

2.1.3&nbsp;&nbsp;&nbsp; Patient type trends

2.1.4&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Market Analysis

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry outlook, 2016 &ndash; 2027 (USD Million)

3.3&nbsp;&nbsp;&nbsp; Major factor analysis

3.3.1&nbsp;&nbsp;&nbsp; Drivers

3.3.1.1&nbsp;&nbsp;&nbsp; Growing diabetes populations base

3.3.1.2&nbsp;&nbsp;&nbsp; Advent of artificial intelligence and big data in diabetes devices

3.3.1.3&nbsp;&nbsp;&nbsp; Rising healthcare expenditure on diabetes

3.3.1.4&nbsp;&nbsp;&nbsp; Growing awareness about technologically advanced products

3.3.1.5&nbsp;&nbsp;&nbsp; Favorable reimbursement policies

3.3.1.6&nbsp;&nbsp;&nbsp; Rising number of product launches

3.3.1.7&nbsp;&nbsp;&nbsp; Increasing technological collaboration

3.3.2&nbsp;&nbsp;&nbsp; Restraints &amp; challenges

3.3.2.1&nbsp;&nbsp;&nbsp; High cost of advanced devices

3.4&nbsp;&nbsp;&nbsp; Analysis of COVID-19 impact on the industry

3.5&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.6&nbsp;&nbsp;&nbsp; Competitive review, 2020

3.7&nbsp;&nbsp;&nbsp; PEST analysis

Chapter 4&nbsp;&nbsp;&nbsp;North America Digital Diabetes Management Market, By Product Type

4.1&nbsp;&nbsp;&nbsp; Key segment trends

4.2&nbsp;&nbsp;&nbsp; Devices

4.2.1&nbsp;&nbsp;&nbsp; By device

4.2.2&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027 (USD Million)

4.2.2.1&nbsp;&nbsp;&nbsp; Smart glucose Meters

4.2.2.1.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027 (USD Million)

4.2.2.2&nbsp;&nbsp;&nbsp; Smart CGM

4.2.2.2.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027 (USD Million)

4.2.2.3&nbsp;&nbsp;&nbsp; Smart insulin pumps &amp; Patches

4.2.2.3.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027 (USD Million)

4.2.2.4&nbsp;&nbsp;&nbsp; Smart insulin pens

4.2.2.4.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027 (USD Million)

4.2.3&nbsp;&nbsp;&nbsp; By device type

4.2.3.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027 (USD Million)

4.2.3.1.1&nbsp;&nbsp;&nbsp; Wearable

4.2.3.1.1.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027 (USD Million)

4.2.3.1.2&nbsp;&nbsp;&nbsp; Handheld

4.2.3.1.2.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027 (USD Million)

4.3&nbsp;&nbsp;&nbsp; Services

4.3.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027 (USD Million)

4.3.2&nbsp;&nbsp;&nbsp; Apps

4.3.2.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027 (USD Million)

4.3.3&nbsp;&nbsp;&nbsp; Software

4.3.3.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027 (USD Million)

Chapter 5&nbsp;&nbsp;&nbsp;North America Digital Diabetes Management Market, By Patient Type

5.1&nbsp;&nbsp;&nbsp; Key segment trends

5.2&nbsp;&nbsp;&nbsp; Type 1

5.2.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027 (USD Million)

5.3&nbsp;&nbsp;&nbsp; Type 2

5.3.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;North America Digital Diabetes Management Market, By End-use

6.1&nbsp;&nbsp;&nbsp; Key segment trends

6.2&nbsp;&nbsp;&nbsp; Hospitals

6.2.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027 (USD Million)

6.3&nbsp;&nbsp;&nbsp; Home settings

6.3.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027 (USD Million)

6.4&nbsp;&nbsp;&nbsp; Diagnostic centers &amp; clinics

6.4.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027 (USD Million)

6.5&nbsp;&nbsp;&nbsp; Others

6.5.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027 (USD Million)

Chapter 7&nbsp;&nbsp;&nbsp;North America Digital Diabetes Management Market, By Country

7.1&nbsp;&nbsp;&nbsp; Market trends

7.2&nbsp;&nbsp;&nbsp; U.S.

7.2.1&nbsp;&nbsp;&nbsp; Market size, by country, 2016 &ndash; 2027 (USD Million)

7.2.2&nbsp;&nbsp;&nbsp; Market size, by product type, 2016 &ndash; 2027 (USD Million)

7.2.2.1&nbsp;&nbsp;&nbsp; Market size, by device, 2016 &ndash; 2027 (USD Million)

7.2.2.2&nbsp;&nbsp;&nbsp; Market size, by device type, 2016 &ndash; 2027 (USD Million)

7.2.2.3&nbsp;&nbsp;&nbsp; Market size, by services, 2016 &ndash; 2027 (USD Million)

7.2.3&nbsp;&nbsp;&nbsp; Market size, by patient type, 2016-2027 (USD Million)

7.2.4&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027 (USD Million)

7.3&nbsp;&nbsp;&nbsp; Canada

7.3.1&nbsp;&nbsp;&nbsp; Market size, by country, 2016 &ndash; 2027 (USD Million)

7.3.2&nbsp;&nbsp;&nbsp; Market size, by product type, 2016 &ndash; 2027 (USD Million)

7.3.2.1&nbsp;&nbsp;&nbsp; Market size, by device, 2016 &ndash; 2027 (USD Million)

7.3.2.2&nbsp;&nbsp;&nbsp; Market size, by device type, 2016 &ndash; 2027 (USD Million)

7.3.2.3&nbsp;&nbsp;&nbsp; Market size, by services, 2016 &ndash; 2027 (USD Million)

7.3.3&nbsp;&nbsp;&nbsp; Market size, by patient type, 2016-2027 (USD Million)

7.3.4&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027 (USD Million)

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; Competitive dashboard, 2020

8.2&nbsp;&nbsp;&nbsp; Medtronic Plc

8.2.1&nbsp;&nbsp;&nbsp; Business overview

8.2.2&nbsp;&nbsp;&nbsp; Financial data

8.2.3&nbsp;&nbsp;&nbsp; Product landscape

8.2.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.2.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.3&nbsp;&nbsp;&nbsp; Abbott Laboratories

8.3.1&nbsp;&nbsp;&nbsp; Business overview

8.3.2&nbsp;&nbsp;&nbsp; Financial data

8.3.3&nbsp;&nbsp;&nbsp; Product landscape

8.3.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.3.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.4&nbsp;&nbsp;&nbsp; F Hoffmann-La Roche Ltd

8.4.1&nbsp;&nbsp;&nbsp; Business overview

8.4.2&nbsp;&nbsp;&nbsp; Financial data

8.4.3&nbsp;&nbsp;&nbsp; Product landscape

8.4.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.4.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.5&nbsp;&nbsp;&nbsp; Dexcom, Inc

8.5.1&nbsp;&nbsp;&nbsp; Business overview

8.5.2&nbsp;&nbsp;&nbsp; Financial data

8.5.3&nbsp;&nbsp;&nbsp; Product landscape

8.5.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.5.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.6. &nbsp;&nbsp;&nbsp; Sensonics

8.6.1&nbsp;&nbsp;&nbsp; Business overview

8.6.2&nbsp;&nbsp;&nbsp; Financial data

8.6.3&nbsp;&nbsp;&nbsp; Product landscape

8.6.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.6.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.7&nbsp;&nbsp;&nbsp; Insulet Corporation

8.7.1&nbsp;&nbsp;&nbsp; Business overview

8.7.2&nbsp;&nbsp;&nbsp; Financial data

8.7.3&nbsp;&nbsp;&nbsp; Product landscape

8.7.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.7.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.8&nbsp;&nbsp;&nbsp; Tandem Diabetes Care, Inc

8.8.1&nbsp;&nbsp;&nbsp; Business overview

8.8.2&nbsp;&nbsp;&nbsp; Financial data

8.8.3&nbsp;&nbsp;&nbsp; Product landscape

8.8.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.8.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.9&nbsp;&nbsp;&nbsp; Ypsomed

8.9.1&nbsp;&nbsp;&nbsp; Business overview

8.9.2&nbsp;&nbsp;&nbsp; Financial data

8.9.3&nbsp;&nbsp;&nbsp; Product landscape

8.9.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.9.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.10&nbsp;&nbsp;&nbsp; Ascensia Diabetes Care Holdings Ag

8.10.1&nbsp;&nbsp;&nbsp; Business overview

8.10.2&nbsp;&nbsp;&nbsp; Financial data

8.10.3&nbsp;&nbsp;&nbsp; Product landscape

8.10.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.10.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.11&nbsp;&nbsp;&nbsp; Tidepool

8.11.1&nbsp;&nbsp;&nbsp; Business overview

8.11.2&nbsp;&nbsp;&nbsp; Financial data

8.11.3&nbsp;&nbsp;&nbsp; Product landscape

8.11.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.11.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.12&nbsp;&nbsp;&nbsp; Glooko Inc

8.12.1&nbsp;&nbsp;&nbsp; Business overview

8.12.2&nbsp;&nbsp;&nbsp; Financial data

8.12.3&nbsp;&nbsp;&nbsp; Product landscape

8.12.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.12.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.13&nbsp;&nbsp;&nbsp; Dariohealth Corporation

8.13.1&nbsp;&nbsp;&nbsp; Business overview

8.13.2&nbsp;&nbsp;&nbsp; Financial data

8.13.3&nbsp;&nbsp;&nbsp; Product landscape

8.13.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.13.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.14&nbsp;&nbsp;&nbsp; Novo Nordisk A/S

8.14.1&nbsp;&nbsp;&nbsp; Business overview

8.14.2&nbsp;&nbsp;&nbsp; Financial data

8.14.3&nbsp;&nbsp;&nbsp; Product landscape

8.14.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.14.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.15&nbsp;&nbsp;&nbsp; Pendiq

8.15.1&nbsp;&nbsp;&nbsp; Business overview

8.15.2&nbsp;&nbsp;&nbsp; Financial data

8.15.3&nbsp;&nbsp;&nbsp; Product landscape

8.15.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.15.5&nbsp;&nbsp;&nbsp; SWOT analysis

8.16&nbsp;&nbsp;&nbsp; Emperra GmbH E-Health Technologies

8.16.1&nbsp;&nbsp;&nbsp; Business overview

8.16.2&nbsp;&nbsp;&nbsp; Financial data

8.16.3&nbsp;&nbsp;&nbsp; Product landscape

8.16.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.16.5&nbsp;&nbsp;&nbsp; SWOT analysis 
&nbsp;

Request sample

Need Help?

Contact us

Get In Touch

Address

Contact

Phone :

Email:

Company

Information

Links